FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2599686852> ?p ?o ?g. }

• W2599686852 endingPage "216" @default.
• W2599686852 startingPage "197" @default.
• W2599686852 abstract "Adult T-Cell Leukemia/lymphoma (ATL) is the first human malignancy associated with a chronic infection by a retrovirus, the human T-cell lymphotropic virus type I (HTLV-I). ATL occurs, after a long latency period, only in about 5% of 10–20 millions infected individuals. ATL has a dismal prognosis with a median survival of less than 1 year, mainly due to its resistance to chemotherapy and to a profound immunosuppression. The viral oncoprotein, Tax, plays a major role in ATL oncogenic transformation by interfering with cell proliferation, cell cycle, apoptosis, and DNA repair. The diversity in ATL clinical features and prognosis led to Shimoyama classification of ATL into four clinical subtypes (acute, lymphoma, chronic, and smoldering) requiring different therapeutic strategies. Clinical trials, mainly conducted in Japan, demonstrated that combination of chemotherapy could induce acceptable response rate in the lymphoma subtype but not in acute ATL. However, long-term prognosis remains poor for both subtypes, due to a high relapse rate. Similarly, whether managed by a watchful waiting or treated with chemotherapy, the indolent forms (smoldering and chronic) have a poor long-term outcome. An international meta-analysis showed improved survival in the leukemic subtypes of ATL (chronic, smoldering as well as a subset of the acute subtype) with the use of two antiviral agents, zidovudine and interferon-alpha, and accordingly, this combination should be considered the standard first-line treatment in this context. ATL patients with lymphoma subtype benefit from induction chemotherapy, given simultaneously or sequentially with an antiviral combination of zidovudine and interferon-alpha. Allogeneic hematopoietic stem cells transplantation remains a promising and potentially curative approach but is limited to a small number of patients. Novel drugs such as arsenic trioxide in combination with interferon-alpha or monoclonal antibodies such as anti-CXCR4 have shown promising results and warrant further investigation." @default.
• W2599686852 created "2017-04-07" @default.
• W2599686852 creator A5032928140 @default.
• W2599686852 creator A5084578107 @default.
• W2599686852 creator A5088444923 @default.
• W2599686852 creator A5088509972 @default.
• W2599686852 date "2017-01-01" @default.
• W2599686852 modified "2023-10-01" @default.
• W2599686852 title "Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma" @default.
• W2599686852 cites W1542367364 @default.
• W2599686852 cites W1586205537 @default.
• W2599686852 cites W1606216715 @default.
• W2599686852 cites W1849097877 @default.
• W2599686852 cites W1967950546 @default.
• W2599686852 cites W1975685687 @default.
• W2599686852 cites W1976402310 @default.
• W2599686852 cites W1980124550 @default.
• W2599686852 cites W1980348902 @default.
• W2599686852 cites W1983486536 @default.
• W2599686852 cites W1983701224 @default.
• W2599686852 cites W1984215306 @default.
• W2599686852 cites W1986076068 @default.
• W2599686852 cites W1986265440 @default.
• W2599686852 cites W1988266253 @default.
• W2599686852 cites W1995670792 @default.
• W2599686852 cites W2005308066 @default.
• W2599686852 cites W2006933182 @default.
• W2599686852 cites W2009621572 @default.
• W2599686852 cites W2015676630 @default.
• W2599686852 cites W2018644621 @default.
• W2599686852 cites W2021231662 @default.
• W2599686852 cites W2021688817 @default.
• W2599686852 cites W2021834555 @default.
• W2599686852 cites W2022076457 @default.
• W2599686852 cites W2024952906 @default.
• W2599686852 cites W2027001966 @default.
• W2599686852 cites W2028624655 @default.
• W2599686852 cites W2031528009 @default.
• W2599686852 cites W2031541810 @default.
• W2599686852 cites W2031613727 @default.
• W2599686852 cites W2032176053 @default.
• W2599686852 cites W2038982713 @default.
• W2599686852 cites W2039426604 @default.
• W2599686852 cites W2039555815 @default.
• W2599686852 cites W2044896021 @default.
• W2599686852 cites W2051523398 @default.
• W2599686852 cites W2052230214 @default.
• W2599686852 cites W2052854370 @default.
• W2599686852 cites W2055760934 @default.
• W2599686852 cites W2062772646 @default.
• W2599686852 cites W2063937392 @default.
• W2599686852 cites W2064021511 @default.
• W2599686852 cites W2065141696 @default.
• W2599686852 cites W2065226743 @default.
• W2599686852 cites W2069667541 @default.
• W2599686852 cites W2075409569 @default.
• W2599686852 cites W2079011320 @default.
• W2599686852 cites W2079929369 @default.
• W2599686852 cites W2080029028 @default.
• W2599686852 cites W2083682157 @default.
• W2599686852 cites W2085813441 @default.
• W2599686852 cites W2085882015 @default.
• W2599686852 cites W2086143621 @default.
• W2599686852 cites W2091365149 @default.
• W2599686852 cites W2092453476 @default.
• W2599686852 cites W2094831592 @default.
• W2599686852 cites W2098179256 @default.
• W2599686852 cites W2099464793 @default.
• W2599686852 cites W2100128333 @default.
• W2599686852 cites W2104891668 @default.
• W2599686852 cites W2109766870 @default.
• W2599686852 cites W2110025244 @default.
• W2599686852 cites W2110957729 @default.
• W2599686852 cites W2111510691 @default.
• W2599686852 cites W2115786095 @default.
• W2599686852 cites W2116068882 @default.
• W2599686852 cites W2119092367 @default.
• W2599686852 cites W2122932507 @default.
• W2599686852 cites W2123087041 @default.
• W2599686852 cites W2125853173 @default.
• W2599686852 cites W2132599753 @default.
• W2599686852 cites W2132958485 @default.
• W2599686852 cites W2134594325 @default.
• W2599686852 cites W2135121291 @default.
• W2599686852 cites W2147276690 @default.
• W2599686852 cites W2147372038 @default.
• W2599686852 cites W2148895451 @default.
• W2599686852 cites W2158377087 @default.
• W2599686852 cites W2158899188 @default.
• W2599686852 cites W2159293665 @default.
• W2599686852 cites W2162622294 @default.
• W2599686852 cites W2164208359 @default.
• W2599686852 cites W2166075265 @default.
• W2599686852 cites W2166989515 @default.
• W2599686852 cites W2168799171 @default.
• W2599686852 cites W2170522323 @default.
• W2599686852 cites W2171365282 @default.
• W2599686852 cites W2171789198 @default.

• next